Roche has announced the commercial availability of the Avenio Millisect System, a tissue dissection instrument that utilizes an automated digitally assisted process to reliably and efficiently isolate clinically relevant cells from formalin-fixed paraffin-embedded (FFPE) tissue slides.

The Avenio Millisect System addresses challenges inherent in today's tissue dissection practice in the clinical lab workspace where manual dissection lacks consistency and precision, and laser capture microscopy is cumbersome and costly. The introduction of the Avenio Millisect System further exemplifies the company's commitment in creating a simplified workflow that delivers maximal medical value to clinicians and patients.

The Avenio Millisect System offers a much better means to dissect the component that is most relevant for diagnostic testing. The system allows to precisely isolate the tumor component from FFPE tissue specimens in a standardized efficient workflow.


Why is The Government So Bad at Health Care?

 

randox

Digital version